Your browser doesn't support javascript.
loading
TKI rotation-induced persistent deep molecular response in multi-resistant blast crisis of Ph+ CML.
Valent, Peter; Herndlhofer, Susanne; Schneeweiß, Mathias; Boidol, Bernd; Ringler, Anna; Kubicek, Stefan; Gleixner, Karoline V; Hoermann, Gregor; Hadzijusufovic, Emir; Müllauer, Leonhard; Sperr, Wolfgang R; Superti-Furga, Giulio; Mannhalter, Christine.
Afiliación
  • Valent P; Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Austria.
  • Herndlhofer S; Ludwig Boltzmann Cluster Oncology, Medical University of Vienna, Austria.
  • Schneeweiß M; Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Austria.
  • Boidol B; Ludwig Boltzmann Cluster Oncology, Medical University of Vienna, Austria.
  • Ringler A; Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Austria.
  • Kubicek S; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Austria.
  • Gleixner KV; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Austria.
  • Hoermann G; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Austria.
  • Hadzijusufovic E; Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Austria.
  • Müllauer L; Department of Laboratory Medicine, Medical University of Vienna, Austria.
  • Sperr WR; Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Austria.
  • Superti-Furga G; Ludwig Boltzmann Cluster Oncology, Medical University of Vienna, Austria.
  • Mannhalter C; Department of Pathology, Medical University of Vienna, Austria.
Oncotarget ; 8(14): 23061-23072, 2017 Apr 04.
Article en En | MEDLINE | ID: mdl-28416739

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Leucemia Mielógena Crónica BCR-ABL Positiva / Crisis Blástica / Resistencia a Antineoplásicos / Inhibidores de Proteínas Quinasas / Sustitución de Medicamentos Límite: Aged / Female / Humans Idioma: En Revista: Oncotarget Año: 2017 Tipo del documento: Article País de afiliación: Austria

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Leucemia Mielógena Crónica BCR-ABL Positiva / Crisis Blástica / Resistencia a Antineoplásicos / Inhibidores de Proteínas Quinasas / Sustitución de Medicamentos Límite: Aged / Female / Humans Idioma: En Revista: Oncotarget Año: 2017 Tipo del documento: Article País de afiliación: Austria